Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Recursion Pharmaceuticals Inc., 3 years.
Recursion Pharmaceuticals Inc.
Director
Rapport Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 1, 2024 | Recursion Pharmaceuticals Inc. | Grant or award | +1,843 | — | — |
| Jun 3, 2024 | Recursion Pharmaceuticals Inc. | Grant or award | +13,097 | — | — |
| Apr 26, 2024 | Beam Therapeutics Inc. | Grant or award | +12,500 | — | — |
| Apr 1, 2024 | Beam Therapeutics Inc. | Open-market sale | −5,446 | $32.12 | $174,926 |
| Apr 1, 2024 | Recursion Pharmaceuticals Inc. | Grant or award | +1,467 | — | — |
| Mar 31, 2024 | Beam Therapeutics Inc. | Grant or award | +27,500 | — | — |
| Jul 13, 2023 | Recursion Pharmaceuticals Inc. | Open-market sale | −8,275 | $12.59 | $104,182 |
| Jul 12, 2023 | Recursion Pharmaceuticals Inc. | Open-market sale | −24,302 | $11.25 | $273,398 |
| Jul 12, 2023 | Recursion Pharmaceuticals Inc. | Open-market sale | −78,071 | $12.15 | $948,563 |
| Jul 12, 2023 | Recursion Pharmaceuticals Inc. | Open-market sale | −3,195 | $13.18 | $42,110 |
| Jul 12, 2023 | Recursion Pharmaceuticals Inc. | Open-market sale | −3,157 | $14.08 | $44,451 |
| Jun 16, 2023 | Recursion Pharmaceuticals Inc. | Grant or award | +12,612 | — | — |
| Apr 4, 2023 | Beam Therapeutics Inc. | Open-market sale | −2,186 | $29.09 | $63,591 |
| Apr 3, 2023 | Beam Therapeutics Inc. | Open-market sale | −2,454 | $30.31 | $74,381 |
| Mar 31, 2023 | Beam Therapeutics Inc. | Grant or award | +20,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.